EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modern Approach to Manage Patients With Kaposi Sarcoma

Thomas Bettuzzi, Celeste Lebbe, Chloé Grolleau iD

Journal of Medical Virology · 2025-03 · 97 (3)

DOI: 10.1002/jmv.70294 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 22.03.2025. Verfasst von Thomas Bettuzzi und 2 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP Dermatology Department, Mondor Hospital, Créteil, France. Hauptthemen laut MEDLINE: Sarcoma, Kaposi. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi sarcoma (KS) is a malignancy associated with Kaposi's sarcoma‐associated herpesvirus (KSHV), primarily affecting immunocompromised individuals, such as those with HIV or those receiving immunosuppressive treatments. Immunocompetent individuals may also be affected, illustrating the disease's heterogeneity. KS manifests in different forms—classic, endemic, epidemic, iatrogenic, and in men having sex with men—each with distinct clinical features depending on immune status and geographic area of origin. Although advances in treatment have improved disease control, effective management remains a challenge. This review focuses on the comprehensive approach to investigating and treating KS. It highlights the role of histology, immunohistochemistry, and staging in diagnosing KS and assessing disease extension, together with other KSHV diseases (multicentric Castelman disease, primary effusion lymphoma, and KS inflammatory cytokine syndrome ) . Treatment strategies are discussed, with emphasis on restoring immunity in immunocompromised patients, alongside conventional local therapies, and chemotherapy options like liposomal doxorubicin and paclitaxel for aggressive and extensive forms. Promising emerging therapies, including immunomodulatory agents, antiangiogenic therapies, and checkpoint inhibitors, are also explored. The review emphasizes the importance of personalized treatment based on the patient's underlying condition and KS subtype. It provides an in‐depth look at the pathogenesis, diagnostic methods, and evolving therapeutic approaches, offering valuable insights into improving management and outcomes for KS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, KaposiHumansHerpesvirus 8, HumanImmunocompromised HostDisease ManagementMale

Stichwörter der Autor:innen

Kaposi's sarcoma‐associated herpesvirus (human herpesvirus 8)human herpesvirus 8 (Kaposi's sarcoma‐associated herpesvirus)human immunodeficiency virusvirus classification

Autor:innen und Institutionen

  • AP-HP Dermatology Department, Mondor Hospital, Créteil, France.
  • AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U1342, Université Paris Cité, Diderot-Paris VII, Paris, France.

ORCID-Profile: Chloé Grolleau

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Bettuzzi, T., Lebbe, C., & Grolleau, C. (2025). Modern Approach to Manage Patients With Kaposi Sarcoma. Journal of Medical Virology, 97(3). https://doi.org/10.1002/jmv.70294

Vancouver

Bettuzzi T, Lebbe C, Grolleau C. Modern Approach to Manage Patients With Kaposi Sarcoma. Journal of Medical Virology. 2025;97(3). doi:10.1002/jmv.70294

BibTeX
@article{Bettuzzi2025,
  author = {Bettuzzi, Thomas and Lebbe, Celeste and Grolleau, Chloé},
  title = {Modern Approach to Manage Patients With Kaposi Sarcoma},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {3},
  doi = {10.1002/jmv.70294}
}
Kostenlos starten →